View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


In New Article, BMS Announces Launch of New Initiative to Ensure Patients With Disabilities Can Participate in Clinical Trials

  • July 21, 2022

  • Bristol Myers Squibb has launched the Disability Diversity in Clinical Trials initiative, to ensure that patients with disabilities have access to clinical trials, according to a new article in Endpoint News

    Teaming up with the nonprofit Disability Solutions, the program will begin with a focus on creating recommendations for improving access, speed of enrollment and participation of people with disabilities in trials. According to the CDC, roughly a quarter of US adults live with some type of disability.

    We are pleased to share this article on the exciting work BMS is leading to increase the diversity of patient participants in clinical research. Click here to learn more about the work that BMS, and others, are doing to make research more equitable.